SANDU PHARMACEUTICALS

BSE: 524703 19 Aug 2025

Healthcare

₹ 48.64

Sandu Pharmaceuticals Ltd. specializes in Pharmaceuticals within the Healthcare sector.

SANDU PHARMACEUTICALS

BSE: 524703 19 Aug 2025

Healthcare

₹ 48.64

Sandu Pharmaceuticals Ltd. specializes in Pharmaceuticals within the Healthcare sector.

Book Value

43.5

Dividend Yield

1.64%

Debt to Equity

0.01

Stock P/E

30.5

Market Cap

47.3 Cr

SANDU PHARMACEUTICALS - Share Price & Details

Market Cap

₹47.3

High /Low

69.5 / 43.8

Stock P/E

30.5

Book Value

₹43.5

Dividend Yield

1.64

ROCE

5.44

ROE

₹3.75

Face Value

10.0

PEG Ratio

-35.9

EVEBITDA

₹15.4

Debt

0.48

CMP / FCF

348.0

Debt to equity

₹0.01

NP Ann

1.55

High price all time

86.0

Piotroski score

₹7.0

Graham Number

39.6

No. Eq. Shares

0.97

Net CF

₹0.30

Net profit

1.55

Price to book value

1.12

Interest Coverage

₹22.6

Low price all time

6.14

Industry PE

33.8

Reserves

₹32.4

Free Cash Flow

₹1.93

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
Shyama Computronics and Servic	1.48	0.93	0.67	0.00	5.33	35.5
Triochem Products Ltd.,	3.25	-4.52	NA	-18.44	0
SANDU PHARMACEUTICALS LTD.	141.39	3.26	140.69	0.34	47.3	30.5
Lasa Supergenerics Limited	201.46	-211.19	200.12	-4.22	45	12.9
GENESIS IBRC INDIA LIMITED	NA	-0.22	NA	-0.02	44.9	12.9

Peer Comparison Chart

About SANDU PHARMACEUTICALS

Sandu Pharmaceuticals Ltd., with Security Code 524703, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.

Latest News

Sandu Pharmaceuticals standalone net profit rises 29.41% in the June 2025 quarter

(14 Aug 2025)

Net profit of Sandu Pharmaceuticals rose 29.41% to Rs 0.22 crore in the quarter ended June 2025 as against Rs 0.17 crore during the previous quarter ended...

Sandu Pharmaceuticals announces board meeting date

(05 Aug 2025)

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2025.

Sandu Pharmaceuticals Limited (524703) Stock Experiences Sudden Dip - Massive profits

(04 Aug 2025)

Sandu Pharmaceuticals Limited (524703) Stock Experiences Sudden Dip ✌️【Stock Trends】✌️ Make better decisions with live market news and...

What are LANC company’s key revenue drivers - High-margin investment plays

(28 Jul 2025)

【Investor Trends】✌️ Make informed decisions with live data on stocks, commodities, and futures markets.

Fairchem Organics Limited (543252) Hits 52 Week High - Fastest return on investment

(24 Jul 2025)

【Stock Observations】✌️ Trade with confidence using our real-time alerts and stock forecasts.

Sandu Pharmaceuticals Limited (524703) Gets Regulatory Approval - Superior stock selection

(23 Jul 2025)

Sandu Pharmaceuticals Limited (524703) Gets Regulatory Approval ✌️【Investor Updates】✌️ We decode market signals using trend patterns,...

Quarterly Table

Standalone Consolidated

Metrics	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	17.1	15.3	17.7	16.6	17.4	15.6	17.0	17.7	18.4	14.1
Expenses	16.3	14.8	17.3	15.8	16.9	15.0	16.6	16.8	17.4	13.5
Operating Profit	0.8	0.5	0.4	0.8	0.5	0.6	0.4	0.9	1.0	0.5
OPM %	4.8%	3.16%	2.01%	4.97%	2.94%	3.88%	2.38%	5.18%	5.39%	3.86%
Other Income	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1
Interest	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Depreciation	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.2	0.1
Profit before tax	0.7	0.4	0.2	0.8	0.4	0.7	0.3	0.7	0.8	0.4
Tax %	-31.1%	-27.5%	-47.9%	-27.9%	-45.2%	-17.4%	-38.4%	-32.8%	-30.4%	0%
Net Profit	0.5	0.3	0.1	0.6	0.2	0.6	0.2	0.5	0.6	0.3
EPS in Rs	0.52	0.27	0.11	0.57	0.21	0.5	0.17	0.52	0.57	0

Metrics	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025
Sales	16.8	17.1	15.3	17.7	16.6	17.4	15.6	17.0	17.7	14.1
Expenses	15.9	16.3	14.8	17.3	15.8	16.9	15.0	16.6	16.8	13.5
Operating Profit	0.9	0.8	0.5	0.4	0.8	0.5	0.6	0.4	0.9	0.5
OPM %	5.13%	4.79%	3.15%	2.01%	4.97%	2.93%	3.88%	2.38%	5.14%	3.86%
Other Income	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1
Interest	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Depreciation	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.1
Profit before tax	0.9	0.7	0.4	0.2	0.8	0.4	0.7	0.3	0.7	0.4
Tax %	-31.8%	-31%	-27.9%	-47.9%	-28%	-45.2%	-17.4%	-38.4%	-32.8%	0%
Net Profit	0.6	0.5	0.3	0.1	0.6	0.2	0.6	0.2	0.5	0.3
EPS in Rs	0.64	0.51	0.26	0.11	0.57	0.21	0.62	0.17	1.95	0

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	7%
5 Years:	6%
3 Years:	5%
TTM:	3%

Compounded Profit Growth
10 Years:	11%
5 Years:	17%
3 Years:	10%
TTM:	60%

Stock Price CAGR
10 Years:	7%
5 Years:	28%
3 Years:	-9%
1 Year:	-7%

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	2%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	4%

Stock Price CAGR
10 Years:	7%
5 Years:	28%
3 Years:	-9%
1 Year:	-7%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

SANDU PHARMACEUTICALS

SANDU PHARMACEUTICALS

SANDU PHARMACEUTICALS - Share Price & Details

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About SANDU PHARMACEUTICALS

Latest News

Sandu Pharmaceuticals standalone net profit rises 29.41% in the June 2025 quarter

Sandu Pharmaceuticals announces board meeting date

Sandu Pharmaceuticals Limited (524703) Stock Experiences Sudden Dip - Massive profits

What are LANC company’s key revenue drivers - High-margin investment plays

Fairchem Organics Limited (543252) Hits 52 Week High - Fastest return on investment

Sandu Pharmaceuticals Limited (524703) Gets Regulatory Approval - Superior stock selection

Best AI Driven Stocks in India Best Trading Strategies - Superior capital gains

What drives TELA Bio Inc. stock price - Explosive trading opportunities

5 Emerging Indian Stocks with High Growth Potential Best Growth Stock Opportunities - Superior capital gains

Stocks to Watch in Energy and Power Sector AI Stock Insights - Phenomenal wealth increase

What analysts say about GLBZ stock - Free Consultation

Indian Stocks with Strong Dividend Potential in 2025 High Return Stock Forecasts - Massive stock growth

Technical Analysis: TPI India Limited (500421) - Consistently high yield

What drives ATCH stock price - Lightning-fast capital gains

Adhatoda Vasica Extract Global Market Expected to Reach $1.82 Billion by 2029

Bacil Pharma Share Price

Has Sandu Pharma. declared dividend?

India Ayurvedic Products Market Size & Forecast to 2033

Sandu Pharmaceuticals Reports Decline in Sales, Faces Financial Challenges in March 2025

Sandu Pharmaceuticals consolidated net profit declines 44.07% in the March 2025 quarter

Cerebra Integrated Technologies reports consolidated net loss of Rs 7.72 crore in the March 2025 quarter

Kothari Products consolidated net profit declines 10.23% in the March 2025 quarter

Sandu Pharmaceuticals Faces Significant Volatility Amid Weak Long-Term Financial Fundamentals

Sandu Pharmaceuticals Faces Increased Volatility Amid Weak Performance Metrics and Market Trends

Live market news, research and portfolio

Goa’s iconic Tito’s planning a stock market foray via stake sale

Bal Pharma standalone net profit declines 7.94% in the December 2024 quarter

Sandu Pharmaceuticals Hits 52-Week Low at Rs 52.6, Declines 25.21% Over Past Year

Sandu Pharmaceuticals Hits 52-Week Low at Rs 53.5, Down 24.80% Yearly

Sandu Pharmaceuticals Hits 52-Week Low at Rs. 53.5 Amid Ongoing Decline

Sandu Pharmaceuticals Reports Positive Financial Results for Q2 2024-25

Sandu Pharmaceuticals consolidated net profit declines 9.09% in the September 2024 quarter

Sandu Pharmaceuticals standalone net profit declines 9.09% in the September 2024 quarter

Sandu Pharmaceuticals standalone net profit declines 9.09% i

Vashu Bhagnani Industries consolidated net profit declines 37.50% in the September 2024 quarter

Remedium Lifecare standalone net profit declines 72.74% in the September 2024 quarter

Q2 Results Today: Hero MotoCorp, Lemon Tree Hotels, HAL, Glenmark Pharma among 1181 companies to post earnings on Nov 14

Moldova's Sandu decries 'unprecedented' meddling as EU referendum goes to wire

Sandu Pharmaceuticals Hits 52-Week Low, Receives Strong Sell Rating from MarketsMOJO

MCX, Rites among over 200 stocks to remain in focus next week for dividend, bonus, split. Do you own any?

Dividend Stocks: Kirloskar Industries, Mazagon Dock, NALCO among others to trade ex-dividend next week; Full list here | Stock Market News

Dividend Stocks: Kirloskar Industries, Mazagon Dock, NALCO among others to trade ex-dividend next week; Full list here

Sandu Pharma Consolidated June 2024 Net Sales at Rs 17.05 crore, down 3.46% Y-o-Y

Sandu Pharma Standalone June 2024 Net Sales at Rs 17.05 crore, down 3.46% Y-o-Y

Sandu Pharmaceuticals consolidated net profit rises 54.55% in the June 2024 quarter

Q1 Results 2024: IRFC, NMDC, Apollo Hospitals, Hero MotoCorp, Reliance Power, Hindalco, IRCTC – Key earnings to watch out for this week

Sandu Kumarvin, an Ayurvedic digestive and immunity booster for children launched by Sandu Pharmaceuticals Ltd

Sandu Pharma partners with Vavo Digital for digital influencer campaign

LENOVO INTEL SME ZONE

Stocks to watch: Hindalco, TaMo, SBI, GPT Infra, IIFL Finance | Stock Market News

Stocks to watch: Hindalco, TaMo, SBI, GPT Infra, IIFL Finance

Exploring the Top 10 Ayurvedic Brands of India: A Journey to Holistic Wellness

Sandu Pharmaceuticals Share Price

Buzzing Stocks: Wipro, RVNL, Cyient, Bajaj Fin, NHPC, Torrent Power, ITC, ICICI Bank & others

5 Best Pharma Penny Stocks in India

Buzzing Stocks: Paytm, Tata Consumer, Nykaa, Britannia, Kotak Mahindra, others in news

Beyond Three Generations: Making business future-proof | Lifestyle News | English Manorama

Why family businesses fail at succession – stubborn seniors, ‘helicopter landings’

Union minister Shripad Naik felicitated eminent Ayurvedic doctors on the occasion of Dhanvantari Pujan and National Ayurveda Day

Five Ayurvedic Doctors to be felicitated on National Ayurveda Day, Nov 11

5 city ayurveda doctors awarded for their work

Sandu Pharmaceuticals Splits: Splits, Split History, Stock Split History

Sandu Pharmaceuticals Profit Loss: Check Sandu Pharmaceuticals Profit & Loss Account Annual Statement

Sandu Pharmaceuticals Profit Loss: Check Sandu Pharmaceuticals Profit & Loss Account Interim Statement

Sandu Pharmaceuticals shines on inking MoU with Bach Ma Van Xuan Pharmaceuticals

Why are shares of JP Associates, Va Tech Wabag, JP Power, Rail Vikas Nigam and Sandu Pharma, rallying today?

Stocks that will see action on December 12, 2022

‘Har Din Har Ghar Ayurveda’- National Ayurveda Day Celebrated by Sandu Pharmaceuticals Ltd

'Har Din Har Ghar Ayurveda'- National Ayurveda Day Celebrated by Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals Share Price Today - Sandu Pharmaceuticals Stock Price Live NSE/BSE

TheSmallBigIdea bags integrated digital marketing mandate for Sandu Pharmaceuticals